Notably, the RhoA/Rho-kinase (ROCK) pathway can be activated by ET-1 to promote myofibroblast differentiation and ECM accumulation in the dermis, thereby markedly participating in the pathophysiology of abnormal scar/keloid formation. This evidence concerns the gene RHOA and keloid.